ABSTRACT Mortality was updated to the end of 1982 for 594 employees exposed to benzene who had been studied previously and for an additional 362 exposed workers not studied previously. Cause specific mortality comparisons were made using United States white male, age, and calendar year adjusted rates. Total mortality was observed to have been significantly below expectation, and this was particularly evident for deaths from accidental causes. Mortality from skin cancer was significantly raised, although there were no unusual or common characteristics among the affected individuals which would suggest a link with exposure to benzene. A non-significant excess of total deaths from leukaemia was noted based on four observed cases; however, all four were myelogenous leukaemias and this represented a significant excess in that subcategory. These and other deaths of possible interest are reviewed in detail. Analyses by work area, duration of exposure, and cumulative dose index did not show patterns suggestive of a causal association between exposure to benzene and any particular cause of death.
There is a large amount of evidence to support the hypothesis that acute myelocytic leukaemia may be a latent effect of overexposure to benzene' (B D Goldstein, unpublished data). Data to support increased risks of other types of leukaemia or other cancers have been reported, but are in need of further evaluation2 3
(O Wong, unpublished data). The exact shape of the dose response curve for the benzene leukaemia association is unknown and has been the source for speculation and controversy.'1 5One of the few studies which has been relied on for risk assessment was reported by Ott et al in 1978.6 They followed 594 Dow, Michigan Division, employees potentially exposed in any of three production areas using benzene. Two deaths from leukaemia were observed compared with one expected to the end of 1973. After excluding cohort members with other hazardous exposure, they observed one death from leukaemia against 0 9 expected. A third subject died of bilateral bronchopneumonia but had myeloblastic leukaemia listed on the death certificate under "other significant conditions." This death was coded to pneumonia consistent with the rules followed by the World Health Organisation. The present study updates the mortality experience of that cohort of 594 with an additional nine years of follow up to the end of 1982, and Accepted 3 February 1986 includes 362 exposed employees not studied originally.
Methods and materials
A detailed description of the chlorobenzol, alkyl benzene, and ethyl cellulose operations in which these employees had potential exposure to benzene was given by Ott et al. 6 That report also should be consulted for summaries of industrial hygiene measurements used in exposure classification, and the methods by which the cohort was identified.
In brief, 594 Table 3 presents the distribution of cohort members by exposure intensity level, and within each level by year of first exposure and duration of exposure. Improvements in exposure conditions over time and job mobility by employees resulted in most having been exposed at more than one intensity level. Nearly a quarter (229 subjects) of the cohort members were exposed in jobs categorised as 30 ppm TWA benzene exposure, and nearly a third (311) were exposed in jobs categorised as 17 ppm TWA. Table 4 shows the overall mortality comparisons for selected causes of death. The all causes SMR for this cohort was 84 (or 83 if the arsenic, asbestos, and vinyl chloride exposed subset is excluded). This represented a significant deficit compared with expectation but was consistent with the general pattern of lower mortality among employees from this plant. 12 A $Significant at a = 0-01, two-tailed. 
